Ngai Hang Victor Chong - 08 Jan 2025 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Reporting relationship: Chief Medical Officer
Issuer ticker: CLSD
Reported as of: 08 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jan 2025, 16:30:07 UTC
Prior SEC filing: 04 Nov 2024
Source filing: View source filing
Reporting owner signature: /s/ Charles Deignan, Attorney-in-Fact

Key filing fact

Ngai Hang Victor Chong filed Form 4 for Clearside Biomedical, Inc. (CLSD) on 10 Jan 2025.

Key facts

This page summarizes Ngai Hang Victor Chong's Form 4 filing for Clearside Biomedical, Inc. (CLSD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2025, 16:30.

Change

Previous filing in this sequence was filed on 04 Nov 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLSD transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 08 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $0.9700
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-fourth of the shares underlying this option vest on January 8, 2026 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.